Literature DB >> 8594569

BTKbase, mutation database for X-linked agammaglobulinemia (XLA).

M Vihinen1, T Iwata, C Kinnon, S P Kwan, H D Ochs, I Vorechovský, C I Smith.   

Abstract

X-linked agammaglobulinemia (XLA) is an immunodeficiency caused by mutations in the gene coding for Bruton's agammaglobulinemia tyrosine kinase (BTK). A database (BTKbase) of BTK mutations has been compiled and the recent update lists 225 entries from 189 unrelated families showing 148 unique molecular events. Each patient is given a unique patient identity number (PIN). Information is included regarding the phenotype including symptoms. Mutations in all the five domains of BTK have been noticed to cause the disease, the most common event being missense mutations. The mutations appear almost uniformly throughout the molecule and frequently affect CpG sites forming arginine residues. A decreased frequency of missense mutations was found in the TH, SH3 and upper lobe of the kinase domain. The putative structural implications of all the missense mutations are given in the database.

Entities:  

Mesh:

Year:  1996        PMID: 8594569      PMCID: PMC145577          DOI: 10.1093/nar/24.1.160

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  57 in total

1.  Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinaemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase.

Authors:  I Vorechovský; L Luo; G de Saint Basile; L Hammarström; A D Webster; C I Smith
Journal:  Hum Mol Genet       Date:  1995-12       Impact factor: 6.150

2.  Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia.

Authors:  D C Saffran; O Parolini; M E Fitch-Hilgenberg; D J Rawlings; D E Afar; O N Witte; M E Conley
Journal:  N Engl J Med       Date:  1994-05-26       Impact factor: 91.245

3.  Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.

Authors:  M de Weers; R G Mensink; M E Kraakman; R K Schuurman; R W Hendriks
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

4.  Binding of G protein beta gamma-subunits to pleckstrin homology domains.

Authors:  K Touhara; J Inglese; J A Pitcher; G Shaw; R J Lefkowitz
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

5.  Absence of xid mutation in X-linked agammaglobulinaemia.

Authors:  I Vorechovsky; J N Zhou; L Hammarström; C I Smith; J D Thomas; W E Paul; L D Notarangelo; E Bernatowska-Matuszkiewicz
Journal:  Lancet       Date:  1993-08-28       Impact factor: 79.321

6.  Tec homology (TH) adjacent to the PH domain.

Authors:  M Vihinen; L Nilsson; C I Smith
Journal:  FEBS Lett       Date:  1994-08-22       Impact factor: 4.124

7.  Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction.

Authors:  G Cheng; Z S Ye; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

8.  Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis.

Authors:  L A Bradley; A K Sweatman; R C Lovering; A M Jones; G Morgan; R J Levinsky; C Kinnon
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

9.  An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency.

Authors:  B Duriez; P Duquesnoy; F Dastot; P Bougnères; S Amselem; M Goossens
Journal:  FEBS Lett       Date:  1994-06-13       Impact factor: 4.124

10.  Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).

Authors:  Q Zhu; M Zhang; D J Rawlings; M Vihinen; T Hagemann; D C Saffran; S P Kwan; L Nilsson; C I Smith; O N Witte; S H Chen; H D Ochs
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Early B cell defects.

Authors:  H B Gaspar; M E Conley
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  Subcellular localization of Grb2 by the adaptor protein Dok-3 restricts the intensity of Ca2+ signaling in B cells.

Authors:  Björn Stork; Konstantin Neumann; Ingo Goldbeck; Sebastian Alers; Thilo Kähne; Michael Naumann; Michael Engelke; Jürgen Wienands
Journal:  EMBO J       Date:  2007-02-08       Impact factor: 11.598

Review 3.  X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase.

Authors:  C I Smith; C M Bäckesjö; A Berglöf; L J Brandén; T Islam; P T Mattsson; A J Mohamed; S Müller; B Nore; M Vihinen
Journal:  Springer Semin Immunopathol       Date:  1998

4.  BTKbase, mutation database for X-linked agammaglobulinemia (XLA)

Authors:  M Vihinen; B H Belohradsky; R N Haire; E Holinski-Feder; S P Kwan; I Lappalainen; H Lehväslaiho; T Lester; A Meindl; H D Ochs; J Ollila; I Vorechovsky; M Weiss; C I Smith
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

5.  Correction of the X-linked immunodeficiency phenotype by transgenic expression of human Bruton tyrosine kinase under the control of the class II major histocompatibility complex Ea locus control region.

Authors:  D Drabek; S Raguz; T P De Wit; G M Dingjan; H F Savelkoul; F Grosveld; R W Hendriks
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

6.  Unusual patterns of exon skipping in Bruton tyrosine kinase are associated with mutations involving the intron 17 3' splice site.

Authors:  R N Haire; Y Ohta; S J Strong; R T Litman; Y Liu; J T Prchal; M D Cooper; G W Litman
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

7.  Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed?

Authors:  S A Weston; M L Prasad; C G Mullighan; H Chapel; E M Benson
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

8.  Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.

Authors:  S R Tzeng; M T Pai; F D Lung; C W Wu; P P Roller; B Lei; C J Wei; S C Tu; S H Chen; W J Soong; J W Cheng
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

9.  Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.

Authors:  R A Brooimans; A J van den Berg; G T Rijkers; L A Sanders; J K van Amstel; M G Tilanus; M J Grubben; B J Zegers
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

10.  Identification of csk tyrosine phosphorylation sites and a tyrosine residue important for kinase domain structure.

Authors:  V Joukov; M Vihinen; S Vainikka; J M Sowadski; K Alitalo; M Bergman
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.